Position in ACIU
as of Mar 31, 2026
· filed Apr 20, 2026
Position Value
$19,307
-$5,473 QoQ
Shares Held
7,021
-11.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ACIU Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Banque Cantonale Vaudoise holds $13,170,474 across 21 Biotechnology names. ACIU ranks #19 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,927 | $3,986,262 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,978 | $1,977,940 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,970 | $1,522,100 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
16,000 | $903,840 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
17,463 | $830,714 | |
| 6 | INSM |
INSMED Inc
|
3,923 | $641,488 | |
| 7 | SMMT |
Summit Therapeutics Inc.
|
23,916 | $453,447 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
862 | $451,231 |
All Filings in ACIU
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $19,307 | 7,021 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $24,780 | 7,892 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $53,291 | 18,440 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $37,433 | 18,440 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $49,951 | 26,712 | Shares | Sole | 2025-05-08 | |
| 2024-09-30 | $70,164 | 18,562 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $101,417 | 25,418 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $160,236 | 54,134 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $274,235 | 54,847 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $229,997 | 80,701 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $238,471 | 80,701 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $153,979 | 65,803 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $86,675 | 42,488 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $69,696 | 22,056 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $80,456 | 22,287 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $86,468 | 21,617 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $252,553 | 51,021 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $349,047 | 52,019 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $568,184 | 71,650 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $543,582 | 71,430 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $301,333 | 58,285 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $272,152 | 55,769 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $76,143 | 11,314 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $80,688 | 11,677 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||